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Background: Leukocytes contribute directly and indirectly to reactive oxygen species (ROS) production. Although
leukocytospermia is defined as the presence of ≥1 × 106 white blood cells/mL (WBC/mL) in a semen sample, the
presence of less than 1×106 WBC/mL (low-level leukocytospermia) can still produce a detectable amount of ROS,
impairing sperm function and lowering the chances of pregnancy. Our objective was to assess the effect of
low-level leukocytospermia on semen quality, ROS levels, and DNA damage in infertile men.
Methods: Semen samples were examined from 472 patients and divided into 3 groups: no seminal leukocytes;
group 2, men with low-level leukoctyospermia (0.1-1.0 × 106 WBC/mL); and group 3, frank leukocytospermia,
(>1.0 × 106. WBC/mL). Semen analysis, leukoctyospermia, reactive oxygen species and DNA fragmentation
was tested.
Results: Conventional semen parameters between the 3 groups were similar. Group 2 patients had significantly
higher levels of ROS and sperm DNA fragmentation (1839.65 ± 2173.57RLU/s; DNA damage: 26.47 ± 19.64%)
compared with group 1 (ROS: 1101.09 ± 5557.54 RLU/s; DNA damage: 19.89 ± 17.31%) (ROS: p = 0.002; DNA
damage: p = 0.047). There was no significant difference in ROS levels between groups 2 and 3.
Conclusions: Patients presenting with low-level leukocytospermia have seminal oxidative stress. Although these
patients are not categorized as leukocytospermic by current World Health Organization (WHO) guidelines, these
men may benefit by treatment with antibiotics, testing for bacterial cultures, or antioxidant supplements to
reduce ROS-induced sperm DNA fragmentation and improve their chances of fertility. The WHO guidelines for
leukocytospermia may need to be revised accordingly.
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Leukocytospermia refers to the presence of leukocytes in
semen. It is defined by the World Health Organization
(WHO) as ≥1 × 106 WBC/mL of semen [1] and is
present in 10% to 20% of infertile men [2]. The condi-
tion can be an indicator of male genital tract infection
or inflammation. However, in the absence of infection, it* Correspondence: agarwaa@ccf.org
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unless otherwise stated.may originate from etiologies such as cigarette smoking,
heavy alcohol use, or age [3-6].
Leukocytes (polymorphonuclear neutrophils and mac-
rophages) have important implications in male fertility
in that they produce reactive oxygen species (ROS). At
low levels, ROS play a physiologic role [7], but at higher
levels, they cause oxidative stress, which overwhelms the
physiological mechanisms of sperm and causes damage.
This damage has been established to occur via lipid per-
oxidation of the plasma membrane [8]. After gaining
entry into the sperm, ROS target genetic materials,
destroying mitochondrial DNA and inhibiting intracellular
ATP production [9,10]. Without proper ATP production,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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result, male infertility can occur. Oxidative stress can also
decrease success rates of assisted reproduction procedures
such as in vitro fertilization (IVF) and intracytoplasmic
sperm injection (ICSI) [12,13].
The WHO threshold for leukocytospermia has previ-
ously been challenged as being too high due to the detri-
mental effects seminal leukocytes have on sperm at lower
levels [14-17]. Leukocyte counts lower than 1.0 × 106
WBC/mL (low-level leukocytospermia) has been shown to
cause a significant decrease of motility and DNA integrity
[15]. In addition, previous studies have reported high
bacterial counts at low levels of leukocytospermia [14],
abnormal sperm morphology at levels of leukocytosper-
mia as low as 0.5 × 106 WBC/mL [18], and impaired
sperm motility with significantly increased levels of cyto-
kines IL-6 and IL-8 in semen with moderately increased
leukocytes [19].
Therefore, our objective was to assess the effects of
low-level leukocytospermia on semen quality and oxida-
tive stress markers (ROS levels and DNA damage) in in-
fertile men in an effort to examine whether the WHO
definition of leukocytospermia should be lowered.
Methods
Subjects
This study was approved by Cleveland Clinic review
board, and all patients provided informed consent. This
observational study used semen samples collected in ac-
cordance with a prospective protocol. Between January
2012 and April 2013, 472 infertile patients presenting to
the Cleveland Clinic Center for Male Fertility underwent
assessment, which included semen analysis. Patients
were excluded if they had azoospermia. The following
clinical data were recorded: age, body mass index (BMI),
volume of semen ejaculate, period of sexual abstinence,
duration of infertility, primary or secondary infertility,
and history of smoking and marijuana and alcohol use.
Semen samples were examined for sperm concentra-
tion, motility and morphology, seminal leukocyte levels
via peroxidase or the Endtz test, reactive oxygen species
by chemiluminescence assay, and sperm DNA damage
by TUNEL assay. The patients were divided into three
groups based on their seminal leukocyte levels: group 1,
no seminal leukocytes; group 2, men with low-level leu-
kocytospermia, defined as 0.1-1.0 × 106 WBC/mL; and
group 3, frank leukocytospermia, defined by the WHO
as >1.0 × 106 WBC/mL.
Semen analysis
Computer-assisted semen analysis was performed in our
andrology laboratory using a Hamilton-Thorne-Integrated
Visual Optical System, version 10, semen analyzer (Hamilton
Thorne Biosciences, Beverly, MA). A 5-μL aliquot wasloaded onto a counting chamber for each semen param-
eter analyzed, and 4–10 fields were examined manually
and by computer-assisted semen analysis. Sperm concen-
tration, motility and morphology using the strict criteria
of Kruger et al. were reported according to 2010 WHO
criteria [1].
Seminal leukocyte quantification
To distinguish the WBCs from immature sperm, only
samples with >5 round cells in high power field (hpf )
were assessed with peroxidase staining (Endtz test) [20].
Peroxidase-positive leukocytes staining brown were counted
using a Makler’s counting chamber (Sefi Medical, Haifa,
Israel) under bright-field microscopy and results reported
as ×106 WBC/mL semen.
Reactive oxygen species
Production of ROS was measured by the chemilumines-
cence assay method using luminol (5-amino-2,3-dihydro-
1,4-phthalazinedione; Sigma Chemical, St. Louis, MO) as
the probe. Ten microliters of 5 mmol/L luminol prepared
in dimethyl sulfoxide (Sigma Chemical) were added to
400 μL of the washed sperm suspension. Levels of ROS
were determined by measuring chemiluminescence with
an Autolumat LB 953 luminometer (AutoLumat Plus LB
953, Oakridge, TN) in the integrated mode for 15 minutes.
The results were expressed as Relative Light Units/sec/
106 sperm (hereafter referred as RLU/s) [21].
Measurement of sperm DNA damage
Sperm DNA damage was quantified using the terminal
deoxynucleotidyl transferase (TdT)-mediated fluorescein-
dUTP nick end labeling (TUNEL) assay kit (Apo-Direct;
Pharmingen, San Diego, CA) [22]. This is based on the
principal that TdT binds to the 3′-hydroxyl (OH) termini
of the single and double strand DNA breaks. It is labeled
with, fluorescein isothiocyanate tagged 2′-deoxyuridine,
5′-triphosphate nucleotides (FITC-dUTP) followed by
flow cytometry. Briefly, after fixation with 3.7% parafor-
maldehyde for 30 minutes on ice, spermatozoa were
washed and resuspended in ice cold 70% ethanol and then
in phosphate buffered saline. The specimens were centri-
fuged at 1600 rpm for 7 minutes, and the pellet was resus-
pended for 60 minutes at 37°C in 50 μL of a staining
solution containing terminal deoxynucleotidyl transferase
(TdT) enzyme, TdT reaction buffer, FITC-dUTP and dis-
tilled water. Both negative (without TdT) and positive
samples (DNase I) were included. After centrifugation, the
cells were washed twice in rinse buffer, resuspended in
0.5 mL of propidium iodide (PI)/ RNase solution, and in-
cubated for 30 minutes in the dark at room temperature
in anticipation of flow cytometry [23]. PI stains total DNA
and FITC-dUTP stains apoptotic cells.
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All fluorescence signals of labeled spermatozoa were ana-
lyzed by the flow cytometer FACScan (Becton Dickinson).
A minimum of 10,000 spermatozoa were examined for
each assay at a flow rate of <100 cells/second. The
sperm population was gated using 90° and forward-angle
light scatter to exclude debris and aggregates. The exci-
tation wavelength was 488 nm supplied by an argon
laser at 15 mW. PI red fluorescence (580–630 nm) was
analyzed in the FL-2 channel. The percentage of PI-
positive cells and the mean fluorescence were calculated
on a 1023-channel scale and analyzed using the flow cyt-
ometer software FlowJo, version 6.4.2 (FlowJo, LLC,
Ashland, OR) [23].
Statistical analysis
Group comparisons were performed with respect to cat-
egorical variables using chi-square or Fisher’s exact tests.
Comparisons of greater than 2 groups with respect to
quantitative variables were performed with Kruskal-Wallis
tests, while 2-group comparisons were performed using
the Wilcoxon Rank Sum test [24]. P < 0.05 was considered
statistically significant.Figure 1 Flow chart demonstrating inclusion and exclusion criteria. T
infertility, only 211 were included in this study. 22 were excluded due to to
excluded due to their history of varicocele. Patients included were of reproResults
Between January 2012 and April 2013, 472 infertile pa-
tients presented to the Cleveland Clinic Center for Male
Fertility; inclusion and exclusion criteria are shown in
Figure 1. Two hundred and eleven eligible patients were
examined. Endtz testing categorized these patients as fol-
lows: group 1, no leukocytospermia (n = 153); group 2,
low-level leukocytospermia (n = 36), and group 3, frank
leukocytospermia, greater than 1 × 106 WBC/mL (n = 22).
Compared to the group 1 (0.0 ± 0.01), the leukocyte count
was significantly different in group 2 (0.54 ± 0.22; P <
0.001) and group 3 (3.78 ± 3.08; P < 0.001) and between
group 2 and group 3 (P < 0.001). There were no significant
differences between the three groups in terms of baseline
clinical characteristics (Table 1) and conventional semen
parameters (concentration, motility, and morphology)
(Table 2).
ROS levels
Compared to 63.2% of patients with ROS levels above our
reference value (>93 RLU/s/106 sperm), the incidence in-
creased to 81.6% in group 2 (P < 0.016) and 92.3% in group
3 (P < 0.011) and it was comparable between group 2 andhis chart demonstrates that while 472 patients initially presented with
o few round cells present in their semen, and 239 patients were
ductive age, and had been deemed infertile between 1–12 years.




0.1–1 × 106 WBC/mL
Group 3
>1 × 106 WBC/mL
P
Patients 153 36 22
Age/years 36.95 ± 6.72 38.92 ± 8.13 39.05 ± 7.41 0.34
BMI kg/m2 29.49 ± 5.17 28.33 ± 4.71 28.55 ± 4.65 0.21
Volume of Seminal Ejaculate (mL) 3.08 ± 1.32 2.91 ± 1.69 2.87 ± 1.26 0.33
Abstinence (days) 4.03 ± 1.92 4.71 ± 3.64 3.41 ± 1.18 0.25
Infertility Duration (y) 2.22 ± 1.76 3.03 ± 2.65 2.50 ± 2.39 0.37
Infertility Status Primary 130 24 15 0.012
Secondary 22 12 7
Smoking Status Yes 37 7 1 0.09
No 113 27 21
Marijuana Status Yes 6 4 1 0.21
No 147 32 21
Alcohol Status Yes 93 18 14 0.5
No 53 16 8
Group 1 = no leukocytospermia; Group 2 = low level leukocytospermia, Group 3 = frank leukocytospermia, all numbers are reported as mean ± SD.
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2) had significantly higher ROS levels (p = 0.001) and
DNA damage (p < 0.05) than patients with no leukocytos-
permia (group 1) (Table 2). Group 3 (frank leukocytosper-
mia) also had significantly higher ROS levels than group 2
and group 1. Figure 2 demonstrates the differences in
ROS levels between the three patient groups.
DNA fragmentation
DNA damage was measured by flow cytometry, using
(FITC-dUTP). These results are shown in Table 2. At a
reference value of 19% DNA damage, the incidence of
DNA damage increased from 39.2% in group 1 to 50%
both in group 2 and group 3. However this was not sta-
tistically significant. Higher levels of DNA damage was
seen in the 0.1-1 × 106 WBC/mL group. Deoxyuridine
triphosphate (dUTP) is the substrate that is added by
the TdT enzyme to the free 3′-OH break-ends of DNA.Table 2 Describing differences in semen parameters, ROS, an
None
Leukocytes (× 106 wbc/mL semen) 0.0 ± 0.01
Concentration (× 106/mL) 53.04 ± 56.76
Motility (%) 48.37 ± 17.42
Normal morphology (%) 3.42 ± 3.12
ROS (RLU/ sec) 116.7
(49; 550.3)
DNA damage (%) 19.89 ± 17.31
The results are presented as mean ± SD for all the parameters except ROS which is
aP <0.05 statistically significant compared to non-leukocytospermic group.
bP <0.05 statistically significant compared to low-level leukocytospermic group.DNA damage is measured by gating the population of
cells as negative or positive. This is indicated by the per-
centage distribution of cells that are negative or positive
for DNA damage. Figure 3 is a representative example
included to illustrate to illustrate the percentage DNA
damage in a negative and a positive sample.
Discussion
In this study only the laboratory parameters were exam-
ined and we did not categorize the patients based on
their clinical diagnosis. Reactive oxygen species are pro-
duced both by morphologically abnormal spermatozoa
as well as by white blood cells - especially the granulo-
cytes. Round cells are examined on every sample as part
of the semen analysis. According to the WHO guidelines
(both 1999 and 2010), round cells are tested for leukocy-
tospermia only if the round cell number on a wet smear
is higher than 5 round cells in high power field ord DNA damage between the 3 groups of patients
Leukocytospermia (× 106 WBC/mL)
0.1–1 million >1 million P
0.54 ± 0.22a 3.78 ± 3.08a,b P < 0.01
69.04 ± 80.72 39.35 ± 39.98 0.97
47.33 ± 25.74 49.23 ± 19.56 0.8
3.56 ± 3.16 4.14 ± 3.79 0.3
944.8 61286.8 <0.001
(127; 3315.4)a (6905; 234876)a,b
26.47 ± 19.64a 24.60 ± 17.47 0.038
presented as median (25th; 75th percentile).
Figure 2 Box plot demonstrating minimum, maximum, median,
and upper and lower quartiles of ROS data. This box-plot
demonstrates the differences in ROS median, range, and upper
and lower quartiles. It demonstrates that the median of the
leukocytospermic group (median: 1,286.8 RLU/sec) is much higher than
both the low leukocytospermic group, and the non-leukocytospermic
group. Additionally, the median of the low leukocytospermic group
(median: 944.8 RLU/sec) is also much higher than the non-
leukocytospermic group (median: 116.7 RLU/sec).
Agarwal et al. Reproductive Biology and Endocrinology 2014, 12:126 Page 5 of 8
http://www.rbej.com/content/12/1/126greater than 1 × 106. We examined the effects of low-
level leukocytospermia (0.1-1.0 × 106 WBC/mL) on
sperm concentration, motility and morphology as well as
on oxidative stress markers of sperm (ROS levels and
DNA damage). We found that while there were noFigure 3 Flow cytometry results for DNA fragmentation. DNA damage w
substrate was added to the TdT enzyme binding with the free 3′-OH termini
gating the population of cells as negative or positive. PI stains total DNA and
that is negative for DNA damage and B: Representative histogram for a sampsignificant changes in semen parameters between the 3
study groups, ROS levels and DNA damage were sig-
nificantly higher in the low-level leukocytospermia
group as compared to the non-leukocytospermia group.
This suggests that levels of leukocytospermia lower
than the current WHO threshold may impact fertility
and may require treatment. It is established that the
leukocytes especially the granulocytes are capable of
producing significantly higher levels of ROS (>1000
fold) compared to morphologically abnormal spermato-
zoa with excessive residual cytoplasm in the mid piece
[25,26]. Our study supports the earlier reports that
show that low levels of leukocytospermia could also
generate ROS [16,17,27,28] and it may have patho-
logical effects [14,18,19].
The age in the 3 groups was similar as shown in
Table 1. ROS is secreted predominantly by leukocytes,
particularly the granulocytes [26]. Morphologically ab-
normal spermatozoa with mid-piece defects such as
presence of extracellular residual cytoplasm also produce
ROS. As shown in Table 2, the highest levels of ROS
were seen in the leukocytospermic group. In this study
we reported only Kruger’s strict morphology criteria and
not WHO criteria which include head, midpiece defects
and tail abnormalities. Certainly prophylactic measures
such as antibiotics may be prescribed to these patients
even in cases of moderate leukocytospermia. The patient
can be asked to provide 1) another semen sample, 2)
undergo a semen culture test and reevaluating a secondas measured by flow cytometry, FITC-deoxyuridine triphosphate (dUTP)
of the single – and double strand DNA. DNA damage was measured by
FITC-dUTP stains apoptotic cells. A: Representative histogram for a sample
le tested positive for DNA damage by flow cytometry.
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solved and leukocyte results are negative.
The WHO establishes the threshold of 1 × 106 WBC/
mL as a pathological level to consider treatment of leuko-
cytospermia. Hamada et al. showed that a 3 week course
of doxycycline treatment (100 g orally, twice daily) of in-
fertile men with leukocyte levels of 0.2-1 × 106 WBC/mL
resulted in significant increases in fertilization rates of pa-
tient groups, with pregnancy rates of almost 50% in leuko-
cytospermic samples [29]. Treating infertile men with
leukocytospermia has had variable results. Treatment with
antioxidants such as a combination of vitamin E, vitamin
C, beta-glucan, papaya, and lactoferrin resulted in a de-
crease in sperm DNA fragmentation [30]. Diet rich in
antioxidants β-carotene (5000 IU), vitamin C (60 mg),
vitamin E (30 UI), and zinc (15 mg) for at least 3 months
as well as fruits and vegetables rich in β-carotene resulted
in a significant decrease in ROS level and improvement in
sperm DNA integrity in couples with previously reported
high ROS and DNA damage. This also resulted in higher
pregnancies and fewer miscarriage or abortion rates [31].
Lackner et al. showed that Cox-2 inhibitor therapy im-
proves the sperm concentration and may reduce leukocyte
counts in men with abacterial leukocytospermia [32].
Additionally, Yadav et al. showed that treatment with a
combination of antibiotic and antioxidant treatment re-
duced the leukocyte count, significantly improved results
of the hypo-osmotic swelling test, and significantly in-
creased the total antioxidant capacity [33]. In that study,
there was also significant reduction of nitric oxide (NO) in
the seminal plasma.
Henkel et al. examined sperm with and without DNA
damage in relation to their success with IVF as well as
ICSI [12]. Their results showed a significant correlation
between peroxidase-positive cells and ROS, between
ROS production and DNA damage, and a tendency to-
wards lower pregnancy rates in women fertilized by
DNA-damaged sperm [12]. The effects of leukocytosper-
mia on fertility are still controversial. However, a previ-
ous study has shown that high levels of leukocytes in
semen resulted in early pregnancy loss with IVF and
ICSI as well as in ectopic pregnancies [13]. Both of these
are pathologies that are serious to the obstetric patient
population, resulting in physical and psychological dam-
age. They were both linked more likely to a male factor,
rather than a female factor [13]. While studies specific-
ally linking leukocytospermia to pregnancy are limited,
the few available show a relationship. Ignoring the possi-
bility that low-level leukocytospermia has a pathologic
effect on male fertility may neglect infertile men with
this condition. In fact, low-level leukocytospermia may
require testing of semen cultures for possible infection
and subsequent treatment to ensure future fertility in
some infertile couples.Leukocytospermia has many implications that may not
yet be entirely clear. It is shown to have a relationship
with oxidative stress and sperm damage, and an eventual
effect on male fertility. Lowering the accepted pathologic
level of leukocytospermia may pave the way for infertile
men who do not meet WHO standards to receive treat-
ment and may give them a chance to bear biological
children. As mentioned, there are already multiple ave-
nues for treatment. These men simply need a cutoff that
is more accurate and up to date. ROS are produced
mainly by granulocytes [20]. In this study we demon-
strated that all samples that were positive for white
blood cells, as confirmed by the peroxidase or the Endtz
test, were also positive for ROS. Interestingly, we did not
see a significant difference in DNA damage in samples
from group 2 compared to group 3 even though the
levels of ROS were significantly higher in group 3. The
plausible reasons for a lack of significant difference be-
tween the two groups are: 1) in addition to oxidative
stress being a major contributor of DNA damage, apop-
tosis also contributes to DNA damage. We did not
measure apoptosis and also did not examine the clinical
diagnosis in these patients. They were categorized solely
on the presence or absence of leukocytes. The lack of a
significant increase in DNA damage in group 3 com-
pared to group 2 may be attributed to the patient distri-
bution in these two groups; these patients may have
adequate antioxidant reserves.
We did not measure the total antioxidant capacity
(TAC) in this study. DNA damage caused by apoptosis
may not translate into DNA damage as measured by
Tunel assay [34]. This is because 1) unlike the somatic
cell, spermatozoa nucleus is separated by the neck and
the mid-piece, so apoptosis markers cannot reach the nu-
clear compartment [35]; 2) spermatozoa possess highly
truncated base excision repair pathways which are not rec-
ognized by the 3-hydroxyl group targeted by terminal
transferases in Tunel reaction and 3) nucleus is highly
compacted and mitochondria activated endonucleases
cannot enter the nuclear compartment. Furthermore
spermatozoa do not possess apurinic/apyrimidinic (AP)
endonuclease 1 (APE1) to create 3-OH breaks. Therefore
Tunel signals are not generated and therefore the damage
does not translate into DNA damage.
There was a 100% correlation between Endtz positive
sample and ROS production. Earlier we reported ROS-
TAC score which is a much stronger predictor of oxida-
tive stress compared to ROS and TAC alone [17,27].
Leukocytospermic contamination is also associated with
a reduced ROS-TAC score. It is difficult to establish a
safe minimum WBC count as even low concentration can
generate ROS and cause DNA damage [16,17,28,34,36].
We concluded that the presence of any WBCs is associ-
ated with oxidative stress and that these may therefore
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samples used for assisted reproduction may help reduce
oxidative stress. We had suggested that the WHO defined
cutoff of 1 × 106 WBC/mL for leukocytospermia may be
too high [16]. As shown in Table 2, both ROS levels and
DNA damage was significant in the low level leukocytosper-
mic group when compared to the non-leukocytospermic
group.
The WHO cutoff has been challenged previously
[14-18]. We are challenging it again, advocating that
even men with lower levels of leukocytospermia may
have risk factors for infertility, and may require treat-
ment. Based on our present study as well as previous
ones, we suggest a new lower threshold for leukocytos-
permia at 0.1-1.0 × 106 WBC/mL.
This area of study is relatively new–whereas other
studies have included low or moderate levels of leukocy-
tospermia in their studies, this is the first study to our
knowledge examining the effects of low-level leukocytos-
permia on oxidative stress markers. We did not examine
the association of leukocyte concentration with infec-
tion. Studies examining the incidence of bacterial infec-
tion with leukocyte concentration are important in
further discriminating the presence of low levels of leu-
koctyospermia and infection. Prescribing antibiotic regi-
men early on may be helpful in reducing the harmful
effects of possible or mild infection. Future studies may
look at specific treatment of low level leukocytospermia
with antioxidants, anti-inflammatory agents, and pos-
sibly antibiotics as well as time-to-pregnancy in couples
with low-level leukocytospermia.
The strengths of our study include a sizeable study
population. However, our research did not show any sig-
nificance between non-leukocytospermia patients and
those with low level leukocytospermia in terms of DNA
damage and we have explained the reason for this lack
of significant increase. We expected to see a relationship
here, and it was not evident. Further research may need
to be undertaken to understand why differences in ROS
were significant, but differences in DNA damage were
not.Conclusions
In conclusion, ROS levels and DNA damage were sig-
nificantly increased in patients with low-level leukocy-
tospermia. This tells us that there is an important
implication to even a reduced number of leukocytes
in the semen. We believe that low-level leukocytosper-
mia is pathological and that treatment should be con-
sidered in these individuals in addition to semen
cultures for underlying infection. The WHO guide-
lines for leukocytospermia may be too high and may
require adjustment.Abbreviations
BMI: Body mass index; FITC: Fluorescein isothiocynate; HPF: High power field;
ROS: Reactive oxygen species; WBC: White blood cells; WHO: World Health
Organization.
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